| Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma H Chiu, P Trisal, C Bjorklund, S Carrancio, EG Toraño, C Guarinos, ... British journal of haematology 185 (2), 240-253, 2019 | 56 | 2019 |
| Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy N Ioannou, PR Hagner, M Stokes, AK Gandhi, B Apollonio, M Fanous, ... Blood, The Journal of the American Society of Hematology 137 (2), 216-231, 2021 | 52 | 2021 |
| Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia N Papakonstantinou, S Ntoufa, M Tsagiopoulou, T Moysiadis, S Bhoi, ... International journal of cancer 144 (11), 2695-2706, 2019 | 26 | 2019 |
| T-cell dynamics in chronic lymphocytic leukemia under different treatment modalities A Vardi, E Vlachonikola, D Papazoglou, F Psomopoulos, K Kotta, ... Clinical Cancer Research 26 (18), 4958-4969, 2020 | 21 | 2020 |
| Understanding the immune-stroma microenvironment in B cell malignancies for effective immunotherapy B Apollonio, N Ioannou, D Papazoglou, AG Ramsay Frontiers in oncology 11, 626818, 2021 | 19 | 2021 |
| Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils HH Encabo, IV Aramburu, M Garcia-Albornoz, M Piganeau, H Wood, ... Cell stem cell 30 (6), 781-799. e9, 2023 | 16 | 2023 |
| Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma B Apollonio, F Spada, N Petrov, D Cozzetto, D Papazoglou, P Jarvis, ... The Journal of clinical investigation 133 (13), 2023 | 13 | 2023 |
| Ibrutinib-based therapy improves anti-tumor T cell killing function allowing effective pairing with anti-PD-L1 immunotherapy compared to traditional FCR chemoimmunotherapy … D Papazoglou, CE Lesnick, V Wang, NE Kay, TD Shanafelt, AG Ramsay Blood 132, 236, 2018 | 13 | 2018 |
| The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy F Arruga, M Rubin, D Papazoglou, A Iannello, N Ioannou, R Moia, ... Haematologica 108 (8), 2101, 2023 | 6 | 2023 |
| Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial D Papazoglou, XV Wang, TD Shanafelt, CE Lesnick, N Ioannou, ... Blood 143 (1), 57-63, 2024 | 5 | 2024 |
| Differential effects of Iberdomide versus revlimid on leukocyte trafficking, immune activation and DLBCL tumor cell killing Y Nakayama, H Chiu, RK Narla, A Shakya, J Gamez, I Wall, ... Blood 138, 718, 2021 | 2 | 2021 |
| S141: Eliciting anti-tumor t cell activity in chronic lymphocytic leukemia with bispecific antibody-based combination therapy D Papazoglou, L Ysebaert, N Ioannou, B Apollonio, P Patten, S Herter, ... HemaSphere 6, 42-43, 2022 | 1 | 2022 |
| Tp63 Contributes to the Apoptosis Resistant Phenotype in Aggressive Chronic Lymphocytic Leukemia S Ntoufa, N Papakonstantinou, D Papazoglou, M Tsagiopoulou, ... Blood 126 (23), 4142, 2015 | 1 | 2015 |
| Exploring the intricate cross-talk between clonal expansion and the bone marrow niche S Ngo, D Papazoglou, HH Encabo, D Bonnet The Francis Crick Institute, 2024 | | 2024 |
| Exploring the intricate cross-talk between clonal expansion and the bone marrow niche S Ngo, D Papazoglou, H Huerga Encabo, D Bonnet Frontiers in Hematology 3, 1334807, 2024 | | 2024 |
| P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA B Apollonio, F Spada, N Petrov, D Cozzetto, P Jarvis, D Papazoglou, ... HemaSphere 7 (S3), e1551940, 2023 | | 2023 |
| Modelling the ability of targeted drugs and immunotherapy to modulate anti-tumour T cell activity in Chronic Lymphocytic Leukaemia D Papazoglou King's College London, 2022 | | 2022 |
| T cell bispecific antibody combination immunotherapy for chronic lymphocytic leukemia D Papazoglou, A Vardi, A Kuhl, P Patten, S Herter, M Bacac, C Klein, ... LEUKEMIA & LYMPHOMA 61, 149-150, 2020 | | 2020 |
| Longitudinal High-Throughput T Cell Repertoire Profiling of Chronic Lymphocytic Leukemia Patients Under Different Types of Treatment: Implications for Combination Strategies A Vardi, E Vlachonikola, N Ioannou, F Psomopoulos, K Kotta, ... Blood 132, 4400, 2018 | | 2018 |
| CONFLICT-OF-INTEREST DISCLOSURE A Vardi, E Vlachonikola, D Papazoglou, F Psomopoulos, K Kotta, ... | | |
